Abstract:Recent genome-wide association studies (GWAS) have revealed shared genetic components among alcohol, opioid, tobacco and cannabis use disorders. However, the extent of the underlying shared causal variants and effector genes, along with their cellular context, remain unclear. We leveraged our existing 3D genomic datasets comprising high-resolution promoter-focused Capture-C/Hi-C, ATAC-seq and RNA-seq across >50 diverse human cell types to focus on genomic regions that coincide with GWAS loci. Using stratified LD regression, we determined the proportion of genome-wide SNP heritability attributable to the features assayed across our cell types by integrating recent GWAS summary statistics for the relevant traits: alcohol use disorder (AUD), tobacco use disorder (TUD), opioid use disorder (OUD) and cannabis use disorder (CanUD). Statistically significant enrichments (P<0.05) were observed in 14 specific cell types, with heritability reaching 9.2-fold for iPSC-derived cortical neurons and neural progenitors, confirming that they are crucial cell types for further functional exploration. Additionally, several pancreatic cell types, notably pancreatic beta cells, showed enrichment for TUD, with heritability enrichments up to 4.8-fold, suggesting genomic overlap with metabolic processes. Further investigation revealed significant positive genetic correlations between T2D with both TUD and CanUD (FDR<0.05) and a significant negative genetic correlation with AUD. Interestingly, after partitioning the heritability for each cell type's cis-regulatory elements, the correlation between T2D and TUD for pancreatic beta cells was greater (r=0.2) than the global genetic correlation value. Our study provides new genomic insights into substance use disorders and implicates cell types where functional follow-up studies could reveal causal variant-gene mechanisms underpinning these disorders.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Reveal the shared and unique 3D genomic features of substance use disorders (SUDs) and determine the specific roles of these features in different cell types**. Specifically, the authors hope to understand the genetic basis of alcohol, opioid, tobacco, and cannabis use disorders (AUD, OUD, TUD, CanUD) and their functional mechanisms in specific cell types. ### Detailed description of the main problems: 1. **Shared and unique genetic variations and effector genes**: - Although recent genome - wide association studies (GWAS) have revealed the shared genetic components among multiple substance use disorders, the specific causal genes of these genetic variations and their roles in different cell types remain unclear. - The authors hope to identify specific gene regulatory elements related to these diseases and their functions in different cell types by integrating high - resolution 3D genomic data (such as Capture - C/Hi - C, ATAC - seq, and RNA - seq). 2. **Cell - type - specific analysis**: - The authors utilized 3D genomic data from more than 50 different human cell types, combined with GWAS results, and quantified the proportion of SNP heritability in different cell types through stratified LD regression. - The study aims to determine which cell types significantly contribute to the genetic susceptibility of these substance use disorders and reveal the specific gene regulatory mechanisms in these cell types. 3. **The relationship between metabolic diseases and substance use disorders**: - The study also explored the role of pancreatic cells (especially β - cells) in TUD and CanUD and found a significant genetic correlation between these cell types and type 2 diabetes (T2D). - This finding suggests that there may be a common genetic basis or regulatory mechanism between metabolic diseases and substance use disorders. ### Conclusion: This study provides new genomics insights, reveals the potential genetic mechanisms of substance use disorders, and points out the key cell types for future functional studies, especially cortical neurons and pancreatic cells. This helps to deeply understand the pathophysiological mechanisms of these diseases and provides a theoretical basis for the development of new treatment strategies. ### Formula representation: - Heritability: \( h^2 \) - Stratified LD regression is used to estimate heritability: \[ h^2_{\text{cell type}}=\frac{\sum (\text{LD score}\times\beta^2)}{\sum \text{LD score}} \] - Genetic correlation: \[ r_g = \frac{\text{Cov}(g_1, g_2)}{\sqrt{\text{Var}(g_1)\times\text{Var}(g_2)}} \] Through these methods, researchers can more accurately analyze the genetic structure of substance use disorders and their specific manifestations in different cell types.

Shared and unique 3D genomic features of substance use disorders across multiple cell types

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Common and Distinguishing Genetic Factors for Substance Use Behavior and Disorder: an Integrated Analysis of Genomic and Transcriptomic Studies from Both Human and Animal Studies

Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the Dorsolateral Prefrontal Cortex

Multi-ancestry meta-analysis of tobacco use disorder identifies 461 potential risk genes and reveals associations with multiple health outcomes

An Association Study Revealed Substantial Effects of Dominance, Epistasis and Substance Dependence Co‐morbidity on Alcohol Dependence Symptom Count

Addiction-Associated Genetic Variants Implicate Brain Cell Type- and Region-Specific Cis-Regulatory Elements in Addiction Neurobiology

Disentangling the shared genetics of ADHD, cannabis use disorder and cannabis use and prediction of cannabis use disorder in ADHD

Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits

Generalized genetic liability to substance use disorders

Genome-wide Association Study Identifies Common Genetic Risk Factors for Alcohol, Heroin and Methamphetamine Dependence

Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking

Epigenetic and Genetic Profiling of Comorbidity Patterns among Substance Dependence Diagnoses

Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample

Integrative genomics approach identifies glial transcriptomic dysregulation and risk in the cortex of individuals with Alcohol Use Disorder

Identification of Novel Loci and Cross-Disorder Pleiotropy Through Multi-Ancestry Genome-Wide Analysis of Alcohol Use Disorder in Over One Million Individuals

Identification of Novel Risk Loci with Shared Effects on Alcoholism, Heroin, and Methamphetamine Dependence

Multi-omics integration analysis identifies novel genes for alcoholism with potential overlap with neurodegenerative diseases

Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder